Next-Generation Anticancer Peptides: Engineering, Nanotheranostics and Clinical Translation
Nanotheranostics · 2026
DOI: 10.7150/ntno.133576 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanotheranostics, 2026. Verfasst von Abhishesh Kumar Mehata und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, University of California, Davis (UC Davis), 3301 C-street, Sacramento, CA 95816, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Peptides, Neoplasms, Theranostic Nanomedicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIDCR NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, School of Medicine, University of California, Davis (UC Davis), 3301 C-street, Sacramento, CA 95816, USA.
- Department of Biochemistry and Molecular Medicine, School of Medicine, UC Davis, 4645 2 nd Avenue, Sacramento, CA 95817, USA.
- UC Davis Comprehensive Cancer Center, 2279 45 th St, Sacramento, CA 95817, USA.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIDCR NIH HHS
Zitieren
APA
Mehata, A. K., Fukui, S., & Izumiya, Y. (2026). Next-Generation Anticancer Peptides: Engineering, Nanotheranostics and Clinical Translation. Nanotheranostics. https://doi.org/10.7150/ntno.133576
Vancouver
Mehata AK, Fukui S, Izumiya Y. Next-Generation Anticancer Peptides: Engineering, Nanotheranostics and Clinical Translation. Nanotheranostics. 2026. doi:10.7150/ntno.133576
BibTeX
@article{Mehata2026,
author = {Mehata, Abhishesh Kumar and Fukui, Shinsuke and Izumiya, Yoshihiro},
title = {Next-Generation Anticancer Peptides: Engineering, Nanotheranostics and Clinical Translation},
journal = {Nanotheranostics},
year = {2026},
doi = {10.7150/ntno.133576}
}
EUVIMED